Myeloma V(L) and V(H) gene sequences reveal a complementary imprint of antigen selection in tumor cells

Blood

Volumn 89, Issue 1, 1997, Pages 219-226

  Sahota, Surinder S ^b   Leo, Regine ^b   Hamblin, Terry J ^b   Stevenson, Freda K ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; GENE CLUSTER; GENE MUTATION; GENE SEQUENCE; HUMAN; MOLECULAR CLONING; MYELOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; BONE MARROW; CANCER STEM CELL; CHEMISTRY; COMPARATIVE STUDY; GENE REARRANGEMENT; GENETICS; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR GENETICS; MULTIPLE MYELOMA; PATHOLOGY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; PARAPROTEIN;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; BONE MARROW; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; MYELOMA PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR STEM CELLS;

EID: 0030614775     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.1.219.219_219_226     Document Type: Article

References (40)

1. Kubagawa, H, Vogler LB, Capra JD, Conrad ME, Lawton AR, Cooper MD: Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point in B-cell differentiation. J Exp Med 150:792, 1979
2. Grogan TM, Durie BGM, Lomen C, Spier C, Wirt DP, Nagle R, Wilson GS, Richter L, Vela E, Maxey V, McDaniel K, Rangel C: Delineation of a novel pre-B cell component in plasma cell myeloma: Immunochemical, immunophenotypic, genotypic, cytologie, cell culture and kinetic features. Blood 70:932, 1987
3. Bakkus MHC, Heirman C, van Riet I, van Camp B, Thielemans K: Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 80:2326, 1992
4. Sahota S, Hamblin T, Oscier DG, Stevenson FK: Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. Leukemia 8:1285, 1994
5. Vescio RA, Cao J, Hong CH, Lee JC, Wu CH, der Danielian M, Wu V, Newman R, Lichtenstein AK, Berenson JR: Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. J Immunol 155:2487, 1995
6. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C: Sequences of Proteins of Immunological Interest (ed 5). Washington, DC, US Department of Health and Human Services, National Institutes of Health, 1991
7. H4-21 gene segment is required to encode anti-I and anti-i specificities. J Immunol 149:2337, 1992
8. H4-34) gene. Blood 87:2846, 1996
9. Bahler DW, Levy R: Clonal evolution of a follicular lymphoma: Evidence for antigen selection. Proc Natl Acad Sci USA 89:6770, 1992
10. Zhu D, Hawkins RE, Hamblin TJ, Stevenson FK: Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes. Br J Haematol 86:505, 1994
11. Berek C: The development of B cells and the B cell repertoire in the microenvironment of the germinal centre. Immunol Rev 126:5, 1992
12. Corradini P, Boccadoro M, Voena C, Pileri A: Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to a Cμ sequence in IgG and IgA secreting multiple myelomas. J Exp Med 178:1091, 1993
13. Billadeau D, Ahmann G, Greipp P, van Ness B: The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 178:1023, 1993
14. Berenson JR, Vescio RA, Hong CH, Cao J, Kim A, Lee CC, Schiller G, Berenson RJ, Lichtenstein AK: Multiple myeloma clones arc derived from a cell late in B lymphoid development. Curr Topics Microbiol Immunol 194:25, 1995
15. Kirkham PM, Schroeder HW Jr: Antibody structure and the evolution of immunoglobulin V gene segments. Semin Immunol 6:347, 1994
16. Kocks C, Rajewsky K: Stable expression and somatic hypermutation of antibody V regions in B cell development pathways. Annu Rev Immunol 7:537, 1989
17. H genes are inherently susceptible to amino acid replacement. Immunol Today 15:367, 1994
18. Tello D, Goldbaum FA, Mariuzza RA, Ysern X, Schwartz FP, Poljak RJ: Three-dimensional structure and thermodynamics of antigen binding by anti-lysozyme antibodies. Biochem Soc Trans 21:943, 1993
19. Leo R, Boeker M, Peest D, Hein R, Bartl R, Gessner JE, Selbach G, Wacker G, Deicher H: Multiparameter analyses of normal and malignant human plasma cells: CD38 ++, CD56+, CD54+, Clg is the common phenotype of myeloma cells. Ann Hematol 64:132, 1992
20. Hawkins RE, Zhu D, Ovecka M, Winter G, Hamblin TJ, Long A, Stevenson FK: Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines. Blood 83:3279, 1994
21. H epertoire. Immunol Today 16:237, 1995
22. Solomon A: Light chains of immunoglobulins: Structural-genetic correlates. Blood 68:603, 1986
23. λ) expressed in early fetal bone marrow. New Biologist 2:689, 1990
24. Cannell PK, Amlot P, Attard M, Hoffbrand AV, Foroni L: Variable κ gene rearrangement in lymphoproliferative disorders and analysis of Vκ gene usage, VJ joining and somatic mutation. Leukemia 8:1139, 1994
25. Kipps TJ, Fong S, Tomhave E, Chen PP, Goldfein R, Carson D: High frequency expression of a conserved κ light-chain variable-region gene in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 84:2916, 1987
26. Zachau HG: The human immunoglobulin κ genes, in Honjo T, Alt FW (eds): Immunoglobulin Genes. San Diego, CA, Academic, 1995, p 173
27. Williams SC, Winter G: Cloning and sequencing of human immunoglobulin V gene segments. Eur J Immunol 23:1456, 1993
28. Klein R, Jaenichen R, Zachau HG: Expressed human immunoglobulin κ genes and their hypermutation. Eur J Immunol 23:3248, 1993
29. H gene mutational patterns indicate different tumor cell status in human myeloma and MGUS. Blood 87:746, 1996
30. Matsuda F, Shin EK, Nagaoka H, Matsumara R, Haino M, Fukita Y, Taka-ishi S, Imai T, Riley JH, Anand R, Soeda E, Honjo T: Structure and physical map of 64 variable segments in the 3′ 0.8-megabase region of the human immunoglobulin heavy chain locus. Nat Genet 3:88, 1993
31. H3 genes J Immunol 145:2751, 1990
32. Gray D: Immunological memory. Annu Rev Immunol 11:49, 1993
33. Schlomchik MJ, Aucoin AH, Pisetsky DS, Weigert MG: Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci USA 84:9150, 1987
34. Ralph QM, Brisco MJ, Joshua DE, Brown R, Gibson J, Morley AA: Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: Evidence from the Ig heavy chain gene. Blood 82:202, 1993
35. Zachau HG: The immunoglobulin κ locus-or-what has been learned from looking closely at one-tenth of a percent of the human genome. Gene 135:167, 1993
36. Cox JPL, Tomlinson IM, Winter G: A directory of human germ-line Vκ segments reveals a strong bias in their usage. Eur J Immunol 24:827, 1994
37. Wagner SD, Martinelli V, Luzzatto L: Similar patterns of Vκ gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulineumia, and myeloma. Blood 83:3647, 1994
38. Bakkus MHC, van Riet I, van Camp B, Thielemans K: Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br J Haematol 87:68, 1994
39. Kosmas C, Viniou N, Stamatopoulos K, Courtenay-Luck N, Papadaki T, Paterakis G, Anagnostou D, Yataganas X, Loukopoulos D: Analysis of κ light chain variable region in multiple myeloma. Blood 86:732a, 1995 (abstr, suppl 1)
40. Milstein C: From the structure of antibodies to the diversification of the immune response. Nobel Lecture. Scand J Immunol 37:385, 1993